Dr. Kempen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts Eye and Ear, 243 Charles Street
and MCM Eye Unit, MyungSung Christian Medical Center, Addis Ababa, Ethiopia
Boston, MA 02114Phone+1 617-573-4494
Summary
- Dr. John H Kempen is dually trained as a clinical ophthalmologist subspecializing in ocular inflammatory and infectious diseases and as a PhD-trained investigator in clinical epidemiology (especially clinical trials). He has pursued a clinician-investigator's career aggressively at Johns Hopkins University for seven years, at the University of Pennsylvania for 11.5 years, and currently at Massachusetts Eye and Ear since 2017. Typically, 80% of his effort is on investigation, focusing on research program development regarding his clinical specialty area of ocular inflammatory diseases, which was an underserved area at the beginning of his career.
In 2014 Dr. Kempen and his colleagues founded the eye care development charity Sight for Souls and as of August 2015, he began hands-on development work in Ethiopia to establish a self-sustaining eye institute in partnership with the Myunsung Comprehensive Specialized Hospital (MCM) with startup funding provided by Sight for Souls while continuing his clinical epidemiology research projects. He became an affiliate of the Harvard School of Medicine Global Health and Social Medicine in 2021, bridging beyond his clinical focus on ophthalmology to broader global health. He currently divides his time between Ethiopia and Boston.
He has more than 200 publications and over 26,000 citations.
Education & Training
- Johns Hopkins University School of Hygiene & Public HealthPhD, Epidemiology, 1997 - 2001
- Johns Hopkins UniversityPh.D., Epidemiology, 2001
- Johns Hopkins University School of Hygiene & Public HealthMHS, Biostatistics, 1997 - 1999
- Johns Hopkins UniversityM.H.S., Biostatistics, 1999
- Johns Hopkins UniversityFellowship, Ocular Immunology/Uveitis, 1997 - 1998
- Johns Hopkins University School of Hygiene & Public HealthMPH, International Health, 1996 - 1997
- Johns Hopkins UniversityM.P.H., International Health, 1997
- University of WashingtonResidency, Ophthalmology, 1993 - 1996
- Santa Clara Valley Medical CenterInternship, Transitional Year, 1992 - 1993
- University of California San Diego School of MedicineClass of 1992
- Stanford UniversityB.S., Biological Sciences, With departmental honors, 1988
Certifications & Licensure
- MA State Medical License 2017 - 2026
- PA State Medical License 2005 - 2018
- MD State Medical License 1997 - 2006
- WA State Medical License 1997 - 1998
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Best Free-Paper Award, Uveitis Section American Academy of Ophthalmology, 2022
- Senior Achievement Award American Academy of Ophthalmology, 2021
- Outstanding Humanitarian Service Aware Harvard Medical School, 2020
- Join now to see all
Clinical Trials
- Multicenter Uveitis Steroid Treatment (MUST) Trial Start of enrollment: 2005 Sep 01
- Fluorometholone as Ancillary Therapy for TT Surgery Start of enrollment: 2013 Nov 01
- FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial Start of enrollment: 2021 Jun 14
Publications & Presentations
PubMed
- 1867 citationsCauses and prevalence of visual impairment among adults in the United States.Nathan Congdon, O'Colmain Bj, Caroline C W Klaver, Ronald Klein, Beatriz Munoz
Archives of Ophthalmology. 2004-04-01 - 2081 citationsPrevalence of age-related macular degeneration in the United States.David S. Friedman, O'Colmain Bj, Beatriz Munoz, Sandra C. Tomany, Catherine A. McCarty
Archives of Ophthalmology. 2004-04-01 - 1726 citationsGlobal Causes of Blindness and Distance Vision Impairment 1990-2020: A Systematic Review and Meta-AnalysisSeth Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite
The Lancet. Global Health. 2017-12-01
Journal Articles
- Chatbots vs. Human Experts: Evaluating Diagnostic Performance of Chatbots in Uveitis and the Perspectives on AI Adoption in OphthalmologyRojas-Carabali W, Sen A, Agarwal A, Tan G, Cheung CY, Rousselot A, Agrawal R, Liu R, Cifuentes-González C, Elze T, Kempen JH, Sobrin L, Nguyen QD, de-la-Torre A, Lee B..., Ocul Immunol Inflamm, 10/13/2023
- Antiviral treatment for acute retinal necrosis: A systematic review and meta-analysisPutera I, Ridwan AS, Dewi M, Cifuentes-González C, Rojas-Carabali W, Sitompul R, Edwar L, Susiyanti M, Aziza Y, Pavesio C, Chee SP, Mahendradas P, Biswas J, Kempen JH,..., Surv Ophthalmol, 9/27/2023
- Demand for Tertiary Eye Care Services in Developing CountriesSubburaman GB, Hariharan L, Ravilla TD, Ravilla RD, Kempen JH, Am J Ophthalmol, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Health utility in the Multicenter Uveitis Steroid Treatment Trial Session Number: 525 Session Title: Clinical and Translational Studies in Ocular InflammationKempen, JH, ARVO Annual Meeting, Life-Changing Research, Seattle, WA, 1/1/2013
- The Prevalence, Incidence and Risk Factors for Exudative Retinal Detachment in UveitisDeepika Shah, Craig Newcomb, Grace Levy-Clarke, Robert Nussenblatt, James Rosenbaum, Eric Suhler, Jennifer Thorne, C. Stephen Foster, Douglas Jabs, and John Kempen, ARVO Meeting, 1/1/2013
- Health utility in the Multicenter Uveitis Steroid Treatment TrialElizabeth Sugar, Alyce Burke, Lea Drye, Janet Holbrook, John Kempen, Jennifer Thorne, Kevin Frick, and Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, ARVO Meeting, 1/1/2013
- Join now to see all
Lectures
- Risk Factors for Prevalent Decreased Visual Acuity in Non-infectious Intermediate, Posterior, & Panuveitis: The MUST TrialPondicherry, India - 1/1/2015
- Academic Ophthalmology and Global Blindness Alleviation: Who is Going to Lead?Philadelphia, PA, 2014; Baltimore, MD, 2015 - 1/1/2015
- Review of Treatment for Inflammatory Eye DiseasesBethesda, MD - 1/1/2015
- Join now to see all
Other
- Primary Results of the Multicenter Uveitis Steroid Treatment TrialKempen JH, American Academy of Ophthalmology, Uveitis Subspecialty Day
San Francisco, CA - 1/1/2010 - Understanding the Safety of Immunomodulatory TherapyKempen JH, American Academy of Ophthalmology, Uveitis Subspecialty Day
San Francisco, CA - 1/1/2010 - Long-term Use of Antimetabolites and BiologicsKempen JH, American Academy of Ophthalmology, Retina Subspecialty Day
San Francisco, CA - 1/1/2009 - Join now to see all
Press Mentions
- May 21, 2017May 21st, 2017
- NIH-Funded Clinical Trial Shows Systemic Therapy Outperforms Intraocular Implant for UveitisMay 7th, 2017
- Short-Term Use of Immunosuppressants Not Linked to Cancer RiskAugust 23rd, 2023
Professional Memberships
- Fellow
External Links
- LinkedInhttps://www.linkedin.com/in/john-kempen-713b6336/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: